About GeneMedi
We develop solutions for the therapeutics and diagnostics industry.
GeneMedi Vision : Curiosity & Creativity to Improve Human Health
New Publication: Sun Yat-Sen University, Hubei University, and GeneMedi co-published a scientific paper on COVID-19 vaccine in the Nature Group Journal of《Communications Biology》
publication
New Publication: Sun Yat-Sen University, Hubei University, and GeneMedi co-published a scientific paper on COVID-19 vaccine in the Nature Group Journal of《Communications Biology》
Previous slide
Next slide
Diagnostics Raw Material (GDU)
Pre-made and custom-made recombinant proteins (Antibodies, Enzymes, Membrane protein,
Factors and other antigens) for drug discovery and diagnostics ingredients, high quality, bulk in stock.
In vitro diagnostic (IVD)
> Diagnostic Cancer
> Diagnostic Infectious Disease
> Diagnostic Inflammation disease
Small Molecules
Veterinary / Animal health
> Ruminants (bovines, ovines, goat, deer)
> Pets (canine, feline, rabbit)
> Swine
Gene Therapy Products & service
High quality, scalable, State-of-the-Art Manufacturing in gene therapy vectors including adenoassociated virus (AAV) vector, lentivirus vector and adenovirus vector.
Adeno-associated virus
(AAV)
Adenovirus
(AdV)
Lentivirus
(LV)
Biologics Products & Service
Membrane Protein & antibodies artificail design, discovery and State-of-the-Art Manufacturing
Pre-made Antibody & Protein & Conjugate Products
INN-Index, bispecific, ADC, nanobody, cytokine, Neutralizing, etc
GTU Products for Biologics discovery
Anti-MMAE, VLP, FcR, Target Expression vector, etc
Hot Targets Products-Antibody & Protein
IO Target, T cell, NK, Macrophage, specific TAA Target, TME
LIBRA HuEasy™: AI-based tool to speed up your antibody humanization accurately
● Faster ● Cost-effective ● User-friendly
For Diagnostics Solution
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
For Biologics Solution
GTU empowers self-capabilities for application development to develop more powerful products and solutions to meet the needs of the biologics industry.
For Gene Therapy Solution
GTU & G-NEXT combine the novel AAV rational design, smart discovery and State-of-the-Art manufacturing to meet the industrial unmet for next generation of gene therapy.
Our Platform
Taurus™ Antibody Discovery Platform
for difficult targets Antibody discovery
LIBRA™-Antibody Engineering Platform
Antibody humanization, maturation, and rational evolution
Antibody Conjugates Platform
ADC, Antibody-microsphere, etc.
G-NEXT™ Plaform
next generation of AAV. X discovery
